Literature DB >> 18802377

Radiocontrast-induced acute kidney injury.

Peter A McCullough1.   

Abstract

Many radiographic studies and procedures use iodinated contrast media and consequently pose the risk of contrast-induced acute kidney injury (AKI). This is an important complication, which accounts for a significant number of cases of hospital-acquired renal failure associated increased hospital length of stay and increased mortality. Sustained reductions in renal blood flow, hypoxic injury, direct cellular toxicity by the contrast media, and superimposed organ injury are all believed to play a role in this form of AKI. Avoidance of dehydration and multimodality prevention measures may reduce rates of this problem in patients at risk. Contrast-induced AKI is likely to remain a significant challenge for specialists in the future since the patient population is aging, chronic kidney disease and diabetes are coming more common, and use of iodinated contrast is growing. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18802377     DOI: 10.1159/000142938

Source DB:  PubMed          Journal:  Nephron Physiol        ISSN: 1660-2137


  27 in total

1.  Transplantation: Coronary angiography prior to renal transplantation.

Authors:  Peter A McCullough
Journal:  Nat Rev Nephrol       Date:  2010-03       Impact factor: 28.314

2.  The RIP1-kinase inhibitor necrostatin-1 prevents osmotic nephrosis and contrast-induced AKI in mice.

Authors:  Andreas Linkermann; Jan-Ole Heller; Agnes Prókai; Joel M Weinberg; Federica De Zen; Nina Himmerkus; Attila J Szabó; Jan H Bräsen; Ulrich Kunzendorf; Stefan Krautwald
Journal:  J Am Soc Nephrol       Date:  2013-07-05       Impact factor: 10.121

3.  Is Endovascular Aneurysm Repair a Relative Contraindication for Patients with Preoperative Renal Dysfunction?

Authors:  Tadashi Furuyama; Toshihiro Onohara; Keita Mikasa; Jyunji Kishimoto; Masafumi Yamashita; Minoru Okamoto; Tsuyoshi Yamamoto; Yasushi Shimoe; Masahiro Okada; Toshiki Takahashi; Yoshimitsu Ishibashi; Mikizou Nakai; Hitoshi Suhara; Fuminari Kasashima; Masamitsu Endo; Takeshi Nishina; Jyunichi Kei; Akihiro Mizuno; Nobuhiro Handa
Journal:  Ann Vasc Dis       Date:  2015-08-18

4.  Preventing radiocontrast-induced nephropathy in chronic kidney disease patients undergoing coronary angiography.

Authors:  Yao-Min Hung; Shoa-Lin Lin; Shih-Yuan Hung; Wei-Chun Huang; Paul Yung-Pou Wang
Journal:  World J Cardiol       Date:  2012-05-26

5.  Kidney Biomarkers of Injury and Repair as Predictors of Contrast-Associated AKI: A Substudy of the PRESERVE Trial.

Authors:  Chirag R Parikh; Caroline Liu; Maria K Mor; Paul M Palevsky; James S Kaufman; Heather Thiessen Philbrook; Steven D Weisbord
Journal:  Am J Kidney Dis       Date:  2019-09-20       Impact factor: 8.860

6.  The incidence, risk factors, and outcomes of acute kidney injury in patients with pyogenic liver abscesses.

Authors:  Seong Eun Yun; Dae-Hong Jeon; Min Jeong Kim; Eun Jin Bae; Hyun Seop Cho; Se-Ho Chang; Dong Jun Park
Journal:  Clin Exp Nephrol       Date:  2014-08-05       Impact factor: 2.801

7.  Incidence and outcome of acute phosphate nephropathy in Iceland.

Authors:  Vala Kolbrún Pálmadóttir; Hjalti Gudmundsson; Sverrir Hardarson; Margrét Arnadóttir; Thorvaldur Magnússon; Margrét B Andrésdóttir
Journal:  PLoS One       Date:  2010-10-19       Impact factor: 3.240

Review 8.  [Contrast induced nephropathy].

Authors:  Walter H Hörl
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

9.  A perioperative strategy for abdominal aortic aneurysm in patients with chronic renal insufficiency.

Authors:  Makoto Haga; Katsuyuki Hoshina; Kunihiro Shigematsu; Toshiaki Watanabe
Journal:  Surg Today       Date:  2015-12-08       Impact factor: 2.549

Review 10.  N-acetylcysteine for the prevention of non-contrast media agent-induced kidney injury: from preclinical data to clinical evidence.

Authors:  Hesamoddin Hosseinjani; Azadeh Moghaddas; Hossein Khalili
Journal:  Eur J Clin Pharmacol       Date:  2013-03-19       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.